GB202117111D0 - Antibodies for use as therapeutics against bacterial infections - Google Patents

Antibodies for use as therapeutics against bacterial infections

Info

Publication number
GB202117111D0
GB202117111D0 GBGB2117111.1A GB202117111A GB202117111D0 GB 202117111 D0 GB202117111 D0 GB 202117111D0 GB 202117111 A GB202117111 A GB 202117111A GB 202117111 D0 GB202117111 D0 GB 202117111D0
Authority
GB
United Kingdom
Prior art keywords
antibodies
bacterial infections
against bacterial
therapeutics against
therapeutics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2117111.1A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kymab Ltd
Original Assignee
Kymab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kymab Ltd filed Critical Kymab Ltd
Priority to GBGB2117111.1A priority Critical patent/GB202117111D0/en
Publication of GB202117111D0 publication Critical patent/GB202117111D0/en
Priority to JP2024531252A priority patent/JP2024543911A/ja
Priority to PCT/EP2022/083353 priority patent/WO2023094628A1/en
Priority to US18/713,540 priority patent/US20250026816A1/en
Priority to CN202280089066.5A priority patent/CN118922440A/zh
Priority to EP22822905.0A priority patent/EP4436994A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1218—Acinetobacter (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB2117111.1A 2021-11-26 2021-11-26 Antibodies for use as therapeutics against bacterial infections Ceased GB202117111D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB2117111.1A GB202117111D0 (en) 2021-11-26 2021-11-26 Antibodies for use as therapeutics against bacterial infections
JP2024531252A JP2024543911A (ja) 2021-11-26 2022-11-25 細菌感染に対する治療薬として使用するための抗体
PCT/EP2022/083353 WO2023094628A1 (en) 2021-11-26 2022-11-25 Antibodies for use as therapeutics against bacterial infections
US18/713,540 US20250026816A1 (en) 2021-11-26 2022-11-25 Antibodies for Use as Therapeutics Against Bacterial Infections
CN202280089066.5A CN118922440A (zh) 2021-11-26 2022-11-25 用作抗细菌感染治疗剂的抗体
EP22822905.0A EP4436994A1 (en) 2021-11-26 2022-11-25 Antibodies for use as therapeutics against bacterial infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2117111.1A GB202117111D0 (en) 2021-11-26 2021-11-26 Antibodies for use as therapeutics against bacterial infections

Publications (1)

Publication Number Publication Date
GB202117111D0 true GB202117111D0 (en) 2022-01-12

Family

ID=80038446

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2117111.1A Ceased GB202117111D0 (en) 2021-11-26 2021-11-26 Antibodies for use as therapeutics against bacterial infections

Country Status (6)

Country Link
US (1) US20250026816A1 (https=)
EP (1) EP4436994A1 (https=)
JP (1) JP2024543911A (https=)
CN (1) CN118922440A (https=)
GB (1) GB202117111D0 (https=)
WO (1) WO2023094628A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121108335B (zh) * 2025-10-17 2026-03-27 广州医科大学附属第一医院（广州呼吸中心） 一种治疗溃疡性结肠炎的抗体及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880078A (en) 1987-06-29 1989-11-14 Honda Giken Kogyo Kabushiki Kaisha Exhaust muffler
CA2109528A1 (en) 1991-05-01 1992-11-02 Gregory A. Prince A method for treating infectious respiratory diseases
US5934272A (en) 1993-01-29 1999-08-10 Aradigm Corporation Device and method of creating aerosolized mist of respiratory drug
US5869046A (en) 1995-04-14 1999-02-09 Genentech, Inc. Altered polypeptides with increased half-life
US6121022A (en) 1995-04-14 2000-09-19 Genentech, Inc. Altered polypeptides with increased half-life
US6019968A (en) 1995-04-14 2000-02-01 Inhale Therapeutic Systems, Inc. Dispersible antibody compositions and methods for their preparation and use
ATE508733T1 (de) 1996-03-04 2011-05-15 Penn State Res Found Materialien und verfahren zur steigerung der zellulären internalisierung
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
CA2277801C (en) 1997-01-16 2002-10-15 Massachusetts Institute Of Technology Preparation of particles for inhalation
WO1999066903A2 (en) 1998-06-24 1999-12-29 Advanced Inhalation Research, Inc. Large porous particles emitted from an inhaler
CN112500489B (zh) * 2021-02-07 2021-05-04 天津一瑞生物科技股份有限公司 一种抗oxa-23型碳青霉烯酶杂交瘤细胞株，单克隆抗体及应用

Also Published As

Publication number Publication date
JP2024543911A (ja) 2024-11-26
WO2023094628A1 (en) 2023-06-01
CN118922440A (zh) 2024-11-08
EP4436994A1 (en) 2024-10-02
US20250026816A1 (en) 2025-01-23

Similar Documents

Publication Publication Date Title
IL277473A (en) Treatment and prevention of microbial infections
IL285770A (en) A method for cleaning bacterial polysaccharides
MX2018001075A (es) Agentes terapeuticos y profilacticos antibacterianos.
MX352760B (es) Metodos para tratar infecciones intrapulmonares.
GB201906653D0 (en) Polypeptides for treatment of bacterial infections
SMT201900692T1 (it) Composizione per l'uso del trattamento delle infezioni batteriche
EP3183002A4 (en) Monoclonal antibodies for treatment of microbial infections
IL278895A (en) Diltiazem for use in the treatment of microbial infections
GB202007452D0 (en) Threrapeutic bacterial composition
EP3195870A4 (en) Agent for promoting growth of nonpathogenic oral indigenous bacteria or agent for improving oral bacterial flora, and composition for oral use
GB202117111D0 (en) Antibodies for use as therapeutics against bacterial infections
GB202117101D0 (en) Antibodies for use as therapeutics against bacterial infections
GB202117107D0 (en) Antibodies for use as therapeutics against bacterial infections
GB202117106D0 (en) Antibodies for use as therapeutics against bacterial infections
HK40070141A (en) Afabicin for use for treating bacterial infections involving biofilm
GB201905642D0 (en) Reducing pulmonary bacterial infections
HK40086190A (en) Treating & preventing microbial infections
HK40086190B (en) Treating & preventing microbial infections
HK40051933A (en) Diltiazem for use in the treatment of microbial infections
HK40087017A (en) Compounds for use in viral infections
GB201909322D0 (en) Microbial infection
HK40037100A (en) Treating & preventing microbial infections
HK40049096B (zh) 治疗和预防微生物感染
HK40068281A (en) Penam derivatives for treating bacterial infections
GB201919420D0 (en) Compositos comprising bacterial strains

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)